0610 Pharmacokinetics And Dose Proportionality Of FT218, An Investigational Controlled Release Formulation Of Sodium Oxybate For Once Nightly Dosing [PDF]
David Monteith +3 more
openaire +1 more source
Effectiveness and Safety of Low-Sodium Oxybate in Participants with Idiopathic Hypersomnia: Primary Results from the DUET Study. [PDF]
Plante DT +10 more
europepmc +1 more source
Clinical pearls for the treatment of narcolepsy. [PDF]
Bulloch MN, Geyer JD.
europepmc +1 more source
Orexin receptor 2 agonists: a pathophysiologic approach to narcolepsy type 1. [PDF]
Arif Z +4 more
europepmc +1 more source
A Comprehensive Review of Current and Emerging Treatments for Narcolepsy Type 1. [PDF]
Xu Q +5 more
europepmc +1 more source
Stimulating amyloid-β clearance in cerebral amyloid angiopathy with low-sodium oxybate and/or non-invasive vagus nerve stimulation (Clear-Brain): study protocol for a randomised pre-post trial. [PDF]
Schriemer SE +12 more
europepmc +1 more source
Therapeutic Use of γ-Hydroxybutyrate: History and Clinical Utility of Oxybates and Considerations of Once- and Twice-Nightly Dosing in Narcolepsy. [PDF]
Roth T.
europepmc +1 more source
Sodium Oxybate: Practical Considerations and Patient Perspectives. [PDF]
Lavender M, Martin C, Anderson D.
europepmc +1 more source
A New Dawn in the Management of Narcolepsy. [PDF]
Thorpy MJ, Morse AM.
europepmc +1 more source
Drug Interactions With Excessive Daytime Sleepiness Treatments. [PDF]
Thomas SV +3 more
europepmc +1 more source

